Woodline Partners LP Celldex Therapeutics, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,014,015 shares of CLDX stock, worth $40.1 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,014,015
Previous 2,341,121
13.97%
Holding current value
$40.1 Million
Previous $79.5 Million
36.0%
% of portfolio
0.38%
Previous 0.72%
Shares
11 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$101 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$93.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$77.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$74.8 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$70.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $932M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...